
|Articles|August 1, 2003
Supplements and Featured Publications
- Examining the Dyslipidemia Constellation
- Volume 9
- Issue 1 Dyslipid
Inflammatory markers are useful risk assessment tools
Author(s)Peter Libby, MD
Advertisement
Articles in this issue
about 22 years ago
NCEP ATP III guidelines incorporate global risk assessmentabout 22 years ago
Case reports illustrate consequences of ATP III in practiceabout 22 years ago
IVUS is redefining atherosclerotic diseaseNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Expands Sotatercept Indication for PAH
2
Proactive MG Management Hinges on Better Coverage and Guidelines
3
Patients, Providers Strongly Favor Oral Therapies in Psoriasis
4
With New OUD Diagnoses on the Rise, More Comprehensive Screenings Needed
5















































